Phoenix Biotech Acquisition Corp.
We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries in the United States and Europe. In particular, we intend to prioritize companies in the life sciences sector where our management team has extensive experience.
(Note: Phoenix Biotech Acquisition Corp. priced its SPAC IPO on Oct. 5, 2021, in line with the term in its prospectus: 15.5 million units at $10 each to raise $155 million.)
|Address||2201 Broadway, Suite 705 Oakland, CA 94612|
|Phone Number||(215) 731-9450|
|View Prospectus:||Phoenix Biotech Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$155.0 mil|
|Manager / Joint Managers||Cantor Fitzgerald|
|Expected To Trade:||10/6/2021|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|